NGVC
Natural Grocers by Vitamin Cottage, Inc.
Company overview
- Market capitalization
- $707.51M
- Employees
- 3,455
- Latest publication
- 2026-09-29
About Natural Grocers by Vitamin Cottage, Inc.
Natural Grocers by Vitamin Cottage, Inc., together with its subsidiaries, retails natural and organic groceries, and dietary supplements in the United States. The company's stores offer natural and organic grocery products, such as organic produce; private label repackaged bulk products, including dried fruits, nuts, grains, granolas, teas, herbs, and spices, as well as peanut and almond butters; private label products comprising grocery staples, household products, bulk foods, and vitamins and dietary supplements, as well as organic eggs, organic flavored coffee, and organic mustard; dry, frozen, and canned groceries; meat and seafood products; dairy products, dairy substitutes, and eggs; prepared foods; bread and baked products; beverages; and beer, wine, and hard cider products. Its stores also provide name-brand supplements, as well as private label dietary supplements; body care products consisting of cosmetics, skin care, hair care, fragrance, and personal care products containing natural and organic ingredients; pet care and food products; household and general merchandise, including cleaning supplies, paper products, and dish and laundry soaps, as well as other common household products, such as diapers; and books and handouts. The company operates its retail stores under the Natural Grocers, Vitamin Cottage, Health Hotline, Natural Grocers by Vitamin Cottage trademark, as well as Vitamin Cottage Natural Grocers and Health Hotline trademarks. The company also offers science-based nutrition education programs to help customers make informed health and nutrition choices. The company was formerly known as Vitamin Cottage Natural Food Markets, Inc. Natural Grocers by Vitamin Cottage, Inc. was founded in 1955 and is headquartered in Lakewood, Colorado.
Financial statements
Income Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 337,376,000USD | 335,579,000USD | 336,141,000USD | 328,705,000USD | 335,769,000USD | 330,221,000USD | 322,661,000USD | 309,082,000USD |
| Cost Of Revenue | 242,863,000USD | 236,720,000USD | 237,115,000USD | 230,426,000USD | 234,021,000USD | 231,397,000USD | 227,299,000USD | 218,751,000USD |
| Gross Profit | 94,513,000USD | 98,859,000USD | 99,026,000USD | 98,279,000USD | 101,748,000USD | 98,824,000USD | 95,362,000USD | 90,331,000USD |
| Selling General Administrative | 12,100,000USD | 10,835,000USD | 7,942,000USD | 10,949,000USD | 11,023,000USD | 11,514,000USD | 10,241,000USD | 9,545,000USD |
| Unclassified Operating Expenses | 63,741,000USD | — | 75,582,000USD | 71,743,000USD | 73,172,000USD | 73,962,000USD | 73,055,000USD | 67,939,000USD |
| Total Operating Expenses | 75,841,000USD | 84,212,000USD | 83,524,000USD | 82,692,000USD | 84,195,000USD | 85,476,000USD | 83,296,000USD | 77,484,000USD |
| Operating Income | 18,672,000USD | 14,647,000USD | 15,502,000USD | 15,587,000USD | 17,553,000USD | 13,348,000USD | 12,066,000USD | 12,847,000USD |
| Interest Expense | 632,000USD | 713,000USD | 696,000USD | 694,000USD | 750,000USD | 923,000USD | 1,053,000USD | 1,052,000USD |
| Net Interest Income | -632,000USD | -713,000USD | -696,000USD | -694,000USD | -750,000USD | -923,000USD | -1,053,000USD | -1,052,000USD |
| Income Before Tax | 17,473,000USD | 13,934,000USD | 14,806,000USD | 14,893,000USD | 16,803,000USD | 12,425,000USD | 11,013,000USD | 11,795,000USD |
| Income Tax Expense | 4,038,999USD | 2,600,000USD | 3,006,000USD | 3,288,000USD | 3,702,000USD | 2,487,000USD | 2,003,000USD | 2,586,000USD |
| Tax Provision | 4,039,000USD | 2,600,000USD | 3,006,000USD | 3,288,000USD | 3,702,000USD | 2,487,000USD | 2,003,000USD | 2,586,000USD |
| Net Income | 13,434,000USD | 11,334,000USD | 11,800,000USD | 11,605,000USD | 13,101,000USD | 9,938,000USD | 9,010,000USD | 9,209,000USD |
| Net Income From Continuing Ops | 13,434,000USD | 11,334,000USD | 11,800,000USD | 11,605,000USD | 13,101,000USD | 9,938,000USD | 9,010,000USD | 9,209,000USD |
| Ebit | 18,105,000USD | 14,647,000USD | 15,502,000USD | 15,587,000USD | 17,553,000USD | 13,348,000USD | 12,066,000USD | 12,847,000USD |
| Ebitda | 26,256,000USD | 22,620,000USD | 23,525,000USD | 23,540,000USD | 25,441,000USD | 21,298,000USD | 19,998,000USD | 20,692,000USD |
| Depreciation And Amortization | 8,151,000USD | 7,973,000USD | 8,023,000USD | 7,953,000USD | 7,888,000USD | 7,950,000USD | 7,932,000USD | 7,845,000USD |
| Reconciled Depreciation | 8,151,000USD | 7,973,000USD | 8,023,000USD | 7,953,000USD | 7,888,000USD | 7,950,000USD | 7,932,000USD | 7,845,000USD |
| Total Other Income Expense Net | -1,199,000USD | -713,000USD | -696,000USD | -694,000USD | -750,000USD | -923,000USD | -1,053,000USD | -1,052,000USD |
| Selling And Marketing Expenses | — | 73,377,000USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,330,836,000USD | 1,241,585,000USD | 1,140,568,000USD | 1,089,625,000USD | 1,055,516,000USD | 1,036,842,000USD | 903,582,000USD | 849,042,000USD |
| Cost Of Revenue | 932,959,000USD | 876,775,000USD | 813,637,000USD | 784,744,000USD | 763,328,000USD | 753,701,000USD | 664,829,000USD | 623,469,000USD |
| Gross Profit | 397,877,000USD | 364,810,000USD | 326,931,000USD | 304,881,000USD | 292,188,000USD | 283,141,000USD | 238,753,000USD | 225,573,000USD |
| Selling General Administrative | 41,428,000USD | 37,048,000USD | 34,366,000USD | 31,562,000USD | 28,355,000USD | 26,780,000USD | 22,837,000USD | 21,506,000USD |
| Unclassified Operating Expenses | 294,459,000USD | 280,785,000USD | 260,896,000USD | 243,164,000USD | 235,506,000USD | 228,612,000USD | 199,150,000USD | 189,014,000USD |
| Total Operating Expenses | 335,887,000USD | 317,833,000USD | 295,262,000USD | 274,726,000USD | 263,861,000USD | 255,392,000USD | 221,987,000USD | 210,520,000USD |
| Operating Income | 61,990,000USD | 46,977,000USD | 31,669,000USD | 30,155,000USD | 28,327,000USD | 27,749,000USD | 16,766,000USD | 15,053,000USD |
| Interest Expense | 3,063,000USD | 4,176,000USD | 3,299,000USD | 2,371,000USD | 2,271,000USD | 2,048,000USD | 4,952,000USD | 4,560,000USD |
| Net Interest Income | -3,063,000USD | -4,176,000USD | -3,299,000USD | -2,371,000USD | -2,271,000USD | -2,048,000USD | -4,952,000USD | -4,560,000USD |
| Income Before Tax | 58,927,000USD | 42,801,000USD | 28,370,000USD | 27,784,000USD | 26,056,000USD | 25,701,000USD | 11,814,000USD | 10,493,000USD |
| Income Tax Expense | 12,483,000USD | 8,866,000USD | 5,127,000USD | 6,419,000USD | 5,475,000USD | 5,692,000USD | 2,398,000USD | -2,168,000USD |
| Tax Provision | 12,483,000USD | 8,866,000USD | 5,127,000USD | 6,419,000USD | 5,475,000USD | 5,692,000USD | 2,398,000USD | -2,168,000USD |
| Net Income | 46,444,000USD | 33,935,000USD | 23,243,000USD | 21,365,000USD | 20,581,000USD | 20,009,000USD | 9,416,000USD | 12,661,000USD |
| Net Income From Continuing Ops | 46,444,000USD | 33,935,000USD | 23,243,000USD | 21,365,000USD | 20,581,000USD | 20,009,000USD | 9,416,000USD | 12,661,000USD |
| Ebit | 61,990,000USD | 46,977,000USD | 31,669,000USD | 30,155,000USD | 28,327,000USD | 27,749,000USD | 16,766,000USD | -14,477,000USD |
| Ebitda | 93,804,000USD | 77,907,000USD | 62,075,000USD | 58,761,000USD | 58,760,000USD | 59,742,000USD | 46,243,000USD | 15,053,000USD |
| Depreciation And Amortization | 31,814,000USD | 30,930,000USD | 30,406,000USD | 28,606,000USD | 30,433,000USD | 31,993,000USD | 29,477,000USD | 29,530,000USD |
| Reconciled Depreciation | 31,814,000USD | 30,930,000USD | 28,906,000USD | 27,906,000USD | 29,633,000USD | 31,193,000USD | 28,977,000USD | 29,430,000USD |
| Total Other Income Expense Net | -3,063,000USD | -4,176,000USD | -3,299,000USD | -2,371,000USD | -2,271,000USD | -2,048,000USD | -4,952,000USD | -4,560,000USD |
| Net Income Applicable To Common Shares | — | — | 23,243,000USD | 21,365,000USD | 20,581,000USD | 20,009,000USD | 9,416,000USD | 12,661,000USD |
| Interest Income | — | — | — | — | — | — | 4,952,000USD | 4,560,000USD |
| Research Development | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 684,701,000USD | 668,556,000USD | 670,504,000USD | 658,997,000USD | 664,590,000USD | 648,879,000USD | 655,476,000USD | 654,386,000USD |
| Intangible Assets | 6,113,000USD | 11,339,000USD | 11,700,000USD | 10,947,000USD | 9,934,000USD | 9,033,000USD | 8,271,000USD | 8,593,000USD |
| Other Current Assets | 7,052,000USD | 5,762,000USD | 6,025,000USD | 6,362,000USD | 4,816,000USD | 4,494,000USD | 4,905,000USD | 5,026,000USD |
| Total Liab | 453,806,000USD | 448,545,000USD | 458,109,000USD | 456,496,000USD | 471,615,000USD | 467,003,000USD | 481,222,000USD | 486,584,000USD |
| Total Stockholder Equity | 230,895,000USD | 220,011,000USD | 212,395,000USD | 202,501,000USD | 192,975,000USD | 181,876,000USD | 174,254,000USD | 167,802,000USD |
| Other Current Liab | 29,500,000USD | 29,509,000USD | 35,309,000USD | 29,439,000USD | 24,830,000USD | 22,471,000USD | -15,541,000USD | 20,951,000USD |
| Common Stock | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD |
| Capital Stock | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD |
| Retained Earnings | 167,197,000USD | 157,218,000USD | 149,339,000USD | 140,293,000USD | 131,443,000USD | 121,093,000USD | 113,904,000USD | 107,175,000USD |
| Good Will | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD |
| Cash | 20,723,000USD | 23,210,000USD | 17,116,000USD | 13,178,000USD | 21,209,000USD | 6,316,000USD | 8,871,000USD | 13,915,000USD |
| Cash And Short Term Investments | 20,723,000USD | 23,210,000USD | 17,116,000USD | 13,178,000USD | 21,209,000USD | 6,316,000USD | 8,871,000USD | 13,915,000USD |
| Total Current Assets | 170,556,000USD | 166,808,000USD | 168,075,000USD | 156,976,000USD | 163,248,000USD | 144,525,000USD | 147,058,000USD | 145,199,000USD |
| Total Current Liabilities | 162,480,000USD | 156,387,000USD | 158,783,000USD | 154,492,000USD | 167,724,000USD | 150,127,000USD | 164,130,000USD | 151,520,000USD |
| Current Deferred Revenue | 1,855,000USD | 2,225,000USD | 1,927,000USD | 2,042,000USD | 1,971,000USD | 2,268,000USD | 1,895,000USD | 1,964,000USD |
| Net Debt | 302,348,000USD | 301,737,000USD | 314,903,000USD | 321,355,000USD | 314,355,000USD | 340,816,000USD | 337,636,000USD | 350,791,000USD |
| Short Term Debt | 41,485,000USD | 40,698,000USD | 40,556,000USD | 40,556,000USD | 40,344,000USD | 39,986,000USD | 79,772,000USD | 41,550,000USD |
| Short Long Term Debt Total | 323,071,000USD | 324,947,000USD | 332,019,000USD | 334,533,000USD | 335,564,000USD | 347,132,000USD | 346,507,000USD | 364,706,000USD |
| Long Term Debt | 1,451,000USD | — | — | — | — | 8,900,000USD | — | 16,600,000USD |
| Net Receivables | 13,095,000USD | 9,950,000USD | 11,966,000USD | 12,810,000USD | 12,449,000USD | 11,895,000USD | 12,610,000USD | 8,921,000USD |
| Inventory | 129,686,000USD | 127,886,000USD | 132,968,000USD | 124,626,000USD | 124,774,000USD | 121,820,000USD | 120,672,000USD | 117,337,000USD |
| Accounts Payable | 89,640,000USD | 83,955,000USD | 80,991,000USD | 82,455,000USD | 91,998,000USD | 75,581,000USD | 88,397,000USD | 79,310,000USD |
| Property Plant Equipment Net | 497,253,000USD | 484,912,000USD | 485,222,000USD | 485,608,000USD | 485,931,000USD | 489,842,000USD | 494,472,000USD | 495,119,000USD |
| Property Plant Equipment Gross | 804,370,000USD | 785,232,000USD | 783,301,000USD | 777,232,000USD | 771,158,000USD | 770,638,000USD | 773,974,000USD | 769,646,000USD |
| Common Stock Shares Outstanding | 23,103,448shares | 23,250,050shares | 23,292,229shares | 23,311,935shares | 23,273,700shares | 23,168,064shares | 23,175,214shares | 23,115,356shares |
| Non Current Assets Total | 514,145,000USD | 501,748,000USD | 502,429,000USD | 502,021,000USD | 501,342,000USD | 504,354,000USD | 508,418,000USD | 509,187,000USD |
| Non Current Liabilities Total | 289,875,000USD | 292,158,000USD | 299,326,000USD | 302,004,000USD | 303,891,000USD | 316,876,000USD | 317,092,000USD | 335,064,000USD |
| Non Currrent Assets Other | 5,569,000USD | 299,000USD | 309,000USD | 268,000USD | 279,000USD | 281,000USD | 458,000USD | 277,000USD |
| Net Working Capital | 8,076,000USD | 10,421,000USD | 9,292,000USD | 2,484,000USD | -4,476,000USD | -5,602,000USD | -17,072,000USD | -6,321,000USD |
| Unclassified Non Current Liabilities | 288,424,000USD | 292,158,000USD | 299,326,000USD | 302,004,000USD | 303,891,000USD | 307,976,000USD | 317,092,000USD | 318,464,000USD |
| Unclassified Equity | 63,652,000USD | 62,747,000USD | 63,010,000USD | 62,162,000USD | 61,486,000USD | 60,737,000USD | 60,304,000USD | 60,581,000USD |
| Unclassified Current Liabilities | — | — | — | — | 8,581,000USD | 9,821,000USD | -5,934,000USD | 6,058,000USD |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 1,687,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 670,504,000USD | 655,476,000USD | 669,185,000USD | 663,108,000USD | 655,079,000USD | 681,792,000USD | 327,114,000USD | 307,083,000USD |
| Intangible Assets | 11,700,000USD | 8,271,000USD | 8,931,000USD | 8,933,000USD | 6,570,000USD | 5,270,000USD | 3,446,000USD | 450,000USD |
| Other Current Assets | 6,025,000USD | 4,905,000USD | 4,151,000USD | 8,738,000USD | 5,828,000USD | 6,185,000USD | 7,728,000USD | 2,590,000USD |
| Total Liab | 458,109,000USD | 481,222,000USD | 498,344,000USD | 507,296,000USD | 512,348,000USD | 508,726,000USD | 170,208,000USD | 160,357,000USD |
| Total Stockholder Equity | 212,395,000USD | 174,254,000USD | 170,841,000USD | 155,812,000USD | 142,731,000USD | 173,066,000USD | 156,906,000USD | 146,726,000USD |
| Other Current Liab | 35,309,000USD | -15,541,000USD | 21,354,000USD | 16,530,000USD | 16,110,000USD | -19,728,000USD | 8,845,000USD | 8,619,000USD |
| Common Stock | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD |
| Capital Stock | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD |
| Retained Earnings | 149,339,000USD | 113,904,000USD | 111,871,000USD | 97,717,000USD | 85,419,000USD | 116,291,000USD | 100,923,000USD | 91,507,000USD |
| Good Will | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD | 5,198,000USD |
| Cash | 17,116,000USD | 8,871,000USD | 18,342,000USD | 12,039,000USD | 23,678,000USD | 28,534,000USD | 6,214,000USD | 9,398,000USD |
| Cash And Short Term Investments | 17,116,000USD | 8,871,000USD | 18,342,000USD | 12,039,000USD | 23,678,000USD | 28,534,000USD | 6,214,000USD | 9,398,000USD |
| Total Current Assets | 168,075,000USD | 147,058,000USD | 152,550,000USD | 140,660,000USD | 135,627,000USD | 143,413,000USD | 115,180,000USD | 110,954,000USD |
| Total Current Liabilities | 158,783,000USD | 164,130,000USD | 154,029,000USD | 137,728,000USD | 133,772,000USD | 129,150,000USD | 83,268,000USD | 79,691,000USD |
| Current Deferred Revenue | 1,927,000USD | 1,895,000USD | 1,866,000USD | 1,757,000USD | 2,157,000USD | 1,819,000USD | 1,410,000USD | 1,453,000USD |
| Net Debt | 314,903,000USD | 337,636,000USD | 351,836,000USD | 381,335,000USD | 377,839,000USD | 371,605,000USD | 51,998,000USD | 44,936,000USD |
| Short Term Debt | 40,556,000USD | 79,772,000USD | 40,290,000USD | 39,708,000USD | 38,234,000USD | 69,984,000USD | 2,090,000USD | 1,472,000USD |
| Short Long Term Debt Total | 332,019,000USD | 346,507,000USD | 370,178,000USD | 393,374,000USD | 401,517,000USD | 400,139,000USD | 58,212,000USD | 54,334,000USD |
| Net Receivables | 11,966,000USD | 12,610,000USD | 10,797,000USD | 10,496,000USD | 8,489,000USD | 8,519,000USD | 5,059,000USD | 4,738,000USD |
| Inventory | 132,968,000USD | 120,672,000USD | 119,260,000USD | 113,756,000USD | 100,546,000USD | 100,175,000USD | 96,179,000USD | 94,228,000USD |
| Accounts Payable | 80,991,000USD | 88,397,000USD | 80,675,000USD | 71,283,000USD | 68,949,000USD | 69,163,000USD | 63,162,000USD | 61,104,000USD |
| Property Plant Equipment Net | 485,222,000USD | 494,472,000USD | 502,111,000USD | 507,865,000USD | 507,154,000USD | 527,264,000USD | 201,635,000USD | 188,768,000USD |
| Property Plant Equipment Gross | 783,301,000USD | 773,974,000USD | 502,111,000USD | 157,179,000USD | 507,154,000USD | 527,264,000USD | 201,635,000USD | 188,768,000USD |
| Common Stock Shares Outstanding | 23,255,274shares | 23,083,903shares | 22,834,316shares | 22,816,614shares | 22,711,003shares | 22,577,646shares | 22,554,603shares | 22,413,038shares |
| Non Current Assets Total | 502,429,000USD | 508,418,000USD | 516,635,000USD | 522,448,000USD | 519,452,000USD | 538,379,000USD | 211,934,000USD | 196,129,000USD |
| Non Current Liabilities Total | 299,326,000USD | 317,092,000USD | 344,315,000USD | 369,568,000USD | 378,576,000USD | 379,576,000USD | 86,940,000USD | 80,666,000USD |
| Non Currrent Assets Other | 309,000USD | 458,000USD | 395,000USD | -15,450,000USD | 530,000USD | 647,000USD | 1,655,000USD | 1,713,000USD |
| Net Working Capital | 9,292,000USD | -17,072,000USD | -1,479,000USD | 2,932,000USD | 1,855,000USD | 14,263,000USD | 31,912,000USD | 31,263,000USD |
| Unclassified Non Current Liabilities | 299,326,000USD | 317,092,000USD | 323,932,000USD | -29,877,000USD | -37,290,000USD | -14,429,000USD | -35,482,000USD | -35,963,000USD |
| Unclassified Equity | 63,010,000USD | 60,304,000USD | 58,924,000USD | 58,049,000USD | 57,266,000USD | 262,245,000USD | 56,296,000USD | 220,868,000USD |
| Unclassified Current Liabilities | — | -5,934,000USD | 8,094,000USD | 6,700,000USD | 6,572,000USD | -11,816,000USD | 7,761,000USD | 7,043,000USD |
| Deferred Long Term Liab | — | — | 18,000USD | 37,000USD | 59,000USD | 14,429,000USD | 17,000USD | 27,068,000USD |
| Other Liab | — | — | 14,427,000USD | 15,902,000USD | 15,293,000USD | 14,429,000USD | 29,773,000USD | 27,068,000USD |
| Other Assets | — | — | 413,000USD | 452,000USD | 530,000USD | 647,000USD | 1,655,000USD | 1,713,000USD |
| Short Long Term Debt | — | — | 1,750,000USD | 1,750,000USD | 1,750,000USD | — | — | — |
| Long Term Debt | — | — | 5,938,000USD | 13,938,000USD | 21,938,000USD | — | 5,692,000USD | 53,598,000USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | 0USD | — | -205,516,000USD | 0USD | -164,655,000USD |
| Net Tangible Assets | — | — | 156,730,000USD | 141,681,000USD | 130,963,000USD | 173,066,000USD | 156,906,000USD | 146,726,000USD |
| Non Current Liabilities Other | — | — | — | 369,568,000USD | 378,576,000USD | 365,147,000USD | 86,940,000USD | 8,895,000USD |
| Unclassified Current Assets | — | — | — | -4,369,000USD | -2,914,000USD | — | — | — |
| Treasury Stock | — | — | — | — | — | — | -359,000USD | -1,040,000USD |
| Short Term Investments | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 13,434,000USD | 11,334,000USD | 11,800,000USD | 11,605,000USD | 13,101,000USD | 9,938,000USD | 9,010,000USD | 9,209,000USD |
| Depreciation | 8,151,000USD | 7,973,000USD | 8,023,000USD | 7,953,000USD | 7,888,000USD | 7,950,000USD | 7,932,000USD | 7,845,000USD |
| Stock Based Compensation | 945,000USD | 857,000USD | 860,000USD | 843,000USD | 822,000USD | 1,435,000USD | 929,000USD | 1,062,000USD |
| Other Non Cash Items | 155,000USD | 12,000USD | 34,433,000USD | -42,000USD | 33,000USD | 66,000USD | 1,715,000USD | 218,000USD |
| Change To Account Receivables | -4,388,000USD | 2,686,000USD | 40,000USD | -687,000USD | -512,000USD | 144,000USD | -3,108,000USD | 182,000USD |
| Change To Inventory | -1,800,000USD | 5,082,000USD | -8,342,000USD | 148,000USD | -2,954,000USD | -1,148,000USD | -3,335,000USD | 15,000USD |
| Change In Working Capital | -360,000USD | 912,000USD | -4,893,000USD | -16,782,000USD | 13,276,000USD | -15,965,000USD | 6,330,000USD | -5,021,000USD |
| Total Cash From Operating Activities | 22,705,000USD | 21,134,000USD | 50,059,000USD | 2,933,000USD | 34,062,000USD | 2,682,000USD | 24,480,000USD | 12,433,000USD |
| Capital Expenditures | -20,781,000USD | -9,601,000USD | -8,077,000USD | -7,099,000USD | 9,678,000USD | -9,678,000USD | -6,825,000USD | -9,301,000USD |
| Free Cash Flow | 1,924,000USD | 11,533,000USD | 41,982,000USD | -4,166,000USD | 43,740,000USD | -6,996,000USD | 17,655,000USD | 3,132,000USD |
| Total Cashflows From Investing Activities | -20,764,000USD | -9,579,000USD | -8,029,000USD | -7,062,000USD | -6,463,000USD | -9,417,000USD | -6,792,000USD | -9,298,000USD |
| Net Borrowings | -933,000USD | -886,000USD | -894,000USD | -980,000USD | -9,882,000USD | 7,931,000USD | -19,245,000USD | 2,253,000USD |
| Total Cash From Financing Activities | -4,428,000USD | -5,461,000USD | -38,092,000USD | -3,902,000USD | -12,706,000USD | 4,180,000USD | -22,732,000USD | -190,000USD |
| Dividends Paid | -3,455,000USD | -3,455,000USD | -2,754,000USD | -2,755,000USD | -2,751,000USD | -2,749,000USD | -2,281,000USD | -2,279,000USD |
| Sale Purchase Of Stock | -40,000USD | -1,120,000USD | 1,242,000USD | -167,000USD | -73,000USD | -1,002,000USD | -1,206,000USD | -164,000USD |
| Change In Cash | -2,487,000USD | 6,094,000USD | 3,938,000USD | -8,031,000USD | 14,893,000USD | -2,555,000USD | -5,044,000USD | 2,945,000USD |
| Begin Period Cash Flow | 23,210,000USD | 17,116,000USD | 13,178,000USD | 21,209,000USD | 6,316,000USD | 8,871,000USD | 13,915,000USD | 10,970,000USD |
| End Period Cash Flow | 20,723,000USD | 23,210,000USD | 17,116,000USD | 13,178,000USD | 21,209,000USD | 6,316,000USD | 8,871,000USD | 13,915,000USD |
| Other Cashflows From Investing Activities | -408,000USD | -7,000USD | 9,999USD | 22,000USD | -16,141,000USD | 261,000USD | -267,000USD | 3,000USD |
| Other Cashflows From Financing Activities | -161,500,000USD | -1,120,000USD | -1,254,000USD | -167,000USD | -8,973,000USD | -1,002,000USD | -1,206,000USD | -164,000USD |
| Unclassified Financing Cash Flow | 161,500,000USD | 1,120,000USD | -34,432,000USD | — | 8,973,000USD | 1,002,000USD | 1,206,000USD | — |
| Investments | — | — | — | -7,062,000USD | -6,463,000USD | -9,417,000USD | -6,792,000USD | -9,298,000USD |
| Unclassified Investing Cash Flow | — | — | — | 7,077,000USD | 6,463,000USD | 9,417,000USD | 7,092,000USD | 9,298,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | -1,058,000USD | — | -1,436,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 46,444,000USD | 33,935,000USD | 23,243,000USD | 21,365,000USD | 20,581,000USD | 20,009,000USD | 9,416,000USD | 12,661,000USD |
| Depreciation | 31,814,000USD | 30,930,000USD | 28,906,000USD | 27,906,000USD | 29,633,000USD | 31,193,000USD | 28,977,000USD | 29,430,000USD |
| Stock Based Compensation | 3,960,000USD | 2,829,000USD | 1,360,000USD | 1,186,000USD | 877,000USD | 1,129,000USD | 1,185,000USD | 810,000USD |
| Other Non Cash Items | 58,000USD | 1,969,000USD | 1,666,000USD | 3,020,000USD | 1,388,000USD | 582,000USD | 262,000USD | 597,000USD |
| Change To Account Receivables | -1,015,000USD | -1,538,000USD | 315,000USD | -2,973,000USD | 30,000USD | -3,418,000USD | -315,000USD | 145,000USD |
| Change To Inventory | -12,296,000USD | -1,412,000USD | -5,504,000USD | -13,210,000USD | -371,000USD | -3,996,000USD | -1,951,000USD | -615,000USD |
| Change In Working Capital | -24,364,000USD | 8,052,000USD | 10,906,000USD | -14,393,000USD | 537,000USD | 9,848,000USD | -6,431,000USD | 5,337,000USD |
| Total Cash From Operating Activities | 55,304,000USD | 73,760,000USD | 64,606,000USD | 39,693,000USD | 53,880,000USD | 66,503,000USD | 37,382,000USD | 42,863,000USD |
| Capital Expenditures | -31,379,000USD | -38,680,000USD | -38,093,000USD | -31,444,000USD | -28,287,000USD | -29,584,000USD | -32,733,000USD | -23,717,000USD |
| Free Cash Flow | 23,925,000USD | 35,080,000USD | 26,513,000USD | 8,249,000USD | 25,593,000USD | 36,919,000USD | 4,649,000USD | 19,146,000USD |
| Total Cashflows From Investing Activities | -30,971,000USD | -38,600,000USD | -37,950,000USD | -31,143,000USD | -27,755,000USD | -29,557,000USD | -31,865,000USD | -23,543,000USD |
| Net Borrowings | -3,825,000USD | -11,298,000USD | -10,779,000USD | -10,719,000USD | 20,864,000USD | -5,717,000USD | -7,500,000USD | -15,200,000USD |
| Total Cash From Financing Activities | -16,088,000USD | -44,631,000USD | -20,353,000USD | -20,189,000USD | -30,981,000USD | -14,626,000USD | -8,701,000USD | -16,443,000USD |
| Dividends Paid | -11,009,000USD | -31,866,000USD | -9,089,000USD | -9,067,000USD | -51,453,000USD | -6,301,000USD | -6,301,000USD | -6,301,000USD |
| Sale Purchase Of Stock | -1,254,000USD | -1,449,000USD | -181,000USD | -403,000USD | -340,000USD | -337,000USD | -421,000USD | -581,000USD |
| Change In Cash | 8,245,000USD | -9,471,000USD | 6,303,000USD | -11,639,000USD | -4,856,000USD | 22,320,000USD | -3,184,000USD | 2,877,000USD |
| Begin Period Cash Flow | 8,871,000USD | 18,342,000USD | 12,039,000USD | 23,678,000USD | 28,534,000USD | 6,214,000USD | 9,398,000USD | 6,521,000USD |
| End Period Cash Flow | 17,116,000USD | 8,871,000USD | 18,342,000USD | 12,039,000USD | 23,678,000USD | 28,534,000USD | 6,214,000USD | 9,398,000USD |
| Other Cashflows From Investing Activities | 230,000USD | -1,059,000USD | 36,000USD | 280,000USD | 443,000USD | -2,805,000USD | 32,000USD | 174,000USD |
| Other Cashflows From Financing Activities | -1,254,000USD | -18,000USD | -304,000USD | 128,597,000USD | 100,508,000USD | 235,738,000USD | 405,900,000USD | -89,000USD |
| Unclassified Operating Cash Flow | -2,608,000USD | -3,955,000USD | -1,475,000USD | — | — | 3,742,000USD | 3,973,000USD | -5,972,000USD |
| Unclassified Financing Cash Flow | 1,254,000USD | — | — | -128,597,000USD | -100,560,000USD | -238,009,000USD | -400,379,000USD | 5,728,000USD |
| Investments | — | -38,600,000USD | -37,950,000USD | -31,143,000USD | -27,755,000USD | -29,557,000USD | -31,865,000USD | -23,543,000USD |
| Unclassified Investing Cash Flow | — | 39,739,000USD | 38,057,000USD | 31,164,000USD | 27,844,000USD | 32,389,000USD | 32,701,000USD | 23,543,000USD |
| Change To Liabilities | — | — | 10,350,000USD | 447,000USD | -2,639,000USD | 16,037,000USD | 2,235,000USD | 5,489,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -11,639,000USD | -4,856,000USD | 22,320,000USD | -3,184,000USD | 2,877,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-03-31 | Product | Dietary Supplements | 63,987,000 | USD | 0001437749-26-015576 |
| Q2 2026Quarterly · 2026-03-31 | Product | Grocery | 243,560,000 | USD | 0001437749-26-015576 |
| Q2 2026Quarterly · 2026-03-31 | Product | Manufactured Product Other | 29,829,000 | USD | 0001437749-26-015576 |
| Q1 2026Quarterly · 2025-12-31 | Product | Dietary Supplements | 60,714,000 | USD | 0001437749-26-003196 |
| Q1 2026Quarterly · 2025-12-31 | Product | Grocery | 243,836,000 | USD | 0001437749-26-003196 |
| Q1 2026Quarterly · 2025-12-31 | Product | Manufactured Product Other | 31,029,000 | USD | 0001437749-26-003196 |
| Q4 2025Quarterly · 2025-09-30 | Product | Dietary Supplements | 63,223,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-09-30 | Product | Grocery | 241,739,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-09-30 | Product | Manufactured Product Other | 31,179,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-09-30 | Product | Dietary Supplements | 252,941,000 | USD | 0001437749-25-037556 |
| FY 2025Yearly · 2025-09-30 | Product | Grocery | 952,171,000 | USD | 0001437749-25-037556 |
| FY 2025Yearly · 2025-09-30 | Product | Manufactured Product Other | 125,724,000 | USD | 0001437749-25-037556 |
| FY 2025Yearly · 2025-09-30 | Product | Vendor Reimbursements | 9,300,000 | USD | 0001437749-25-037556 |
| Q3 2025Quarterly · 2025-06-30 | Product | Dietary Supplements | 61,988,000 | USD | 0001437749-25-025419 |
| Q3 2025Quarterly · 2025-06-30 | Product | Grocery | 235,286,000 | USD | 0001437749-25-025419 |
| Q3 2025Quarterly · 2025-06-30 | Product | Manufactured Product Other | 31,431,000 | USD | 0001437749-25-025419 |
| Q2 2025Quarterly · 2025-03-31 | Product | Dietary Supplements | 66,199,000 | USD | 0001437749-26-015576 |
| Q2 2025Quarterly · 2025-03-31 | Product | Grocery | 238,522,000 | USD | 0001437749-26-015576 |
| Q2 2025Quarterly · 2025-03-31 | Product | Manufactured Product Other | 31,048,000 | USD | 0001437749-26-015576 |
| Q1 2025Quarterly · 2024-12-31 | Product | Dietary Supplements | 61,531,000 | USD | 0001437749-26-003196 |
| Q1 2025Quarterly · 2024-12-31 | Product | Grocery | 236,624,000 | USD | 0001437749-26-003196 |
| Q1 2025Quarterly · 2024-12-31 | Product | Manufactured Product Other | 32,066,000 | USD | 0001437749-26-003196 |
| Q4 2024Quarterly · 2024-09-30 | Product | Dietary Supplements | 62,063,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Product | Grocery | 229,968,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Product | Manufactured Product Other | 30,630,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-09-30 | Product | Dietary Supplements | 243,953,000 | USD | 0001437749-25-037556 |
| FY 2024Yearly · 2024-09-30 | Product | Grocery | 878,263,000 | USD | 0001437749-25-037556 |
| FY 2024Yearly · 2024-09-30 | Product | Manufactured Product Other | 119,369,000 | USD | 0001437749-25-037556 |
| FY 2024Yearly · 2024-09-30 | Product | Vendor Reimbursements | 7,900,000 | USD | 0001437749-25-037556 |
| Q3 2024Quarterly · 2024-06-30 | Product | Dietary Supplements | 59,966,000 | USD | 0001437749-25-025419 |
| Q3 2024Quarterly · 2024-06-30 | Product | Grocery | 219,040,000 | USD | 0001437749-25-025419 |
| Q3 2024Quarterly · 2024-06-30 | Product | Manufactured Product Other | 30,076,000 | USD | 0001437749-25-025419 |
| FY 2023Yearly · 2023-09-30 | Product | Dietary Supplements | 235,714,000 | USD | 0001437749-25-037556 |
| FY 2023Yearly · 2023-09-30 | Product | Grocery | 796,241,000 | USD | 0001437749-25-037556 |
| FY 2023Yearly · 2023-09-30 | Product | Manufactured Product Other | 108,613,000 | USD | 0001437749-25-037556 |
| FY 2023Yearly · 2023-09-30 | Product | Vendor Reimbursements | 7,100,000 | USD | 0001437749-25-037556 |
| FY 2022Yearly · 2022-09-30 | Product | Dietary Supplements | 227,220,000 | USD | 0001437749-24-037351 |
| FY 2022Yearly · 2022-09-30 | Product | Grocery | 759,328,000 | USD | 0001437749-24-037351 |
| FY 2022Yearly · 2022-09-30 | Product | Manufactured Product Other | 103,077,000 | USD | 0001437749-24-037351 |
| FY 2022Yearly · 2022-09-30 | Product | Vendor Reimbursements | 6,300,000 | USD | 0001437749-24-037351 |
| FY 2021Yearly · 2021-09-30 | Product | Dietary Supplements | 220,000,000 | USD | 0001437749-23-033880 |
| FY 2021Yearly · 2021-09-30 | Product | Grocery | 731,894,000 | USD | 0001437749-23-033880 |
| FY 2021Yearly · 2021-09-30 | Product | Manufactured Product Other | 103,622,000 | USD | 0001437749-23-033880 |
| FY 2021Yearly · 2021-09-30 | Product | Vendor Reimbursements | 5,400,000 | USD | 0001437749-23-033880 |
| FY 2020Yearly · 2020-09-30 | Product | Body Care Pet Care And Other | 103,475,000 | USD | 0001437749-22-028744 |
| FY 2020Yearly · 2020-09-30 | Product | Dietary Supplements | 213,182,000 | USD | 0001437749-22-028744 |
| FY 2020Yearly · 2020-09-30 | Product | Grocery | 720,185,000 | USD | 0001437749-22-028744 |
| FY 2020Yearly · 2020-09-30 | Product | Vendor Reimbursements | 4,500,000 | USD | 0001437749-22-028744 |
| FY 2019Yearly · 2019-09-30 | Product | Body Care Pet Care And Other | 94,844,000 | USD | 0001437749-21-028226 |
| FY 2019Yearly · 2019-09-30 | Product | Dietary Supplements | 188,913,000 | USD | 0001437749-21-028226 |
| FY 2019Yearly · 2019-09-30 | Product | Grocery | 619,825,000 | USD | 0001437749-21-028226 |
| FY 2019Yearly · 2019-09-30 | Product | Vendor Reimbursements | 4,600,000 | USD | 0001437749-21-028226 |
| FY 2018Yearly · 2018-09-30 | Product | Body Care Pet Care And Other | 91,246,000 | USD | 0001437749-20-025108 |
| FY 2018Yearly · 2018-09-30 | Product | Dietary Supplements | 183,485,000 | USD | 0001437749-20-025108 |
| FY 2018Yearly · 2018-09-30 | Product | Grocery | 574,311,000 | USD | 0001437749-20-025108 |
| FY 2018Yearly · 2018-09-30 | Product | Vendor Reimbursements | 4,100,000 | USD | 0001437749-20-025108 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.